Cargando…
A Study of the Immunosuppressive Activity of Methylene Dimethane Sulphonate (MDMS) in Relation to its Effectiveness as an Anti-Tumour Agent
The anti-tumour action of methylene dimethane sulphonate (MDMS) has been further investigated in relation to its immunosuppressive properties. Following a dose of 10 mg/kg, the proportion of permanent regressions of Yoshida lymphosarcoma transplants is lower in animals treated during the first 5 day...
Autores principales: | Fox, B. W., Gregory, Connie J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1972
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008431/ https://www.ncbi.nlm.nih.gov/pubmed/5064536 |
Ejemplares similares
-
The nature of the resistance to methylene dimethane sulphonate in the Yoshida sarcoma.
por: Fox, B. W., et al.
Publicado: (1973) -
A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).
por: Smith, D. B., et al.
Publicado: (1988) -
A Transferable “Resistance Factor” from in vitro Cultured MDMS-Resistant Yoshida Sarcoma Cells
por: Szende, B., et al.
Publicado: (1973) -
Sulphonal
Publicado: (1889) -
Sulphonal
Publicado: (1890)